| Income Statement |
| Total Revenue | 124.50M |
|
| Revenues (USD) | 124.50M |
| Cost of Revenue | 33.49M |
| Gross Profit | 91.01M |
| Operating Expenses | 80.78M |
| Research and Development Expense | 16.56M |
| Selling, General and Administrative Expense | 64.22M |
| Operating Income | 10.22M |
| Income Tax Expense | -15.56M |
| Net Income | 27.57M |
| Net Income Common Stock | 27.57M |
| Net Income Common Stock (USD) | 27.57M |
| Consolidated Income | 27.57M |
| Earnings per Basic Share | 0.13 |
| Earnings per Basic Share (USD) | 0.13 |
| Earnings per Diluted Share | 0.12 |
| Earning Before Interest & Taxes (EBIT) | 12.01M |
| Earning Before Interest & Taxes (USD) | 12.01M |
| Weighted Average Shares | 210.20M |
| Weighted Average Shares Diluted | 220.86M |
| Balance Sheet |
| Cash and Equivalents | 417.25M |
| Cash and Equivalents (USD) | 417.25M |
| Trade and Non-Trade Receivables | 116.99M |
| Current Assets | 557.49M |
| Property, Plant & Equipment Net | 32.95M |
| Total Assets | 757.00M |
| Total Debt | 16.31M |
| Current Liabilities | 278.93M |
| Debt Non-Current | 16.31M |
| Total Liabilities | 320.13M |
| Accumulated Retained Earnings (Deficit) | -531.73M |
| Accumulated Other Comprehensive Income | 5.68M |
| Shareholders Equity | 436.87M |
| Shareholders Equity (USD) | 436.87M |
| Assets Non-Current | 199.51M |
| Total Debt (USD) | 16.31M |
| Deferred Revenue | 213.07M |
| Goodwill and Intangible Assets | 47.89M |
| Liabilities Non-Current | 41.20M |
| Trade and Non-Trade Payables | 3.31M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 4.22M |
| Net Cash Flow from Financing | -40.82M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -26.88M |
| Capital Expenditure | -1.74M |
| Issuance (Purchase) of Equity Shares | -38.97M |
| Net Cash Flow from Investing | -1.83M |
| Net Cash Flow - Investment Acquisitions and Disposals | -88.00K |
| Net Cash Flow from Operations | 15.94M |
| Effect of Exchange Rate Changes on Cash | -182.00K |
| Share Based Compensation | 9.57M |